| Market revenue in 2025 | USD 316.1 million |
| Market revenue in 2033 | USD 1,543.4 million |
| Growth rate | 22.74% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
Germany accounted for a substantial revenue share of Europe's single-cell analysis market. The close cooperation between research institutes, pharmaceutical & biotechnology companies, technology parks, and the government is a significant factor contributing to the market growth in Germany.
For instance, in March 2024, the Berlin Institute of Health (BIH) is focusing on research of single cells for personalized medicine. These types of research indicate the rising potential of single cell analysis in the development of personalized medicines.
Germany is home to major global biotechnology companies, such as Merck KGaA, Eppendorf AG, Sartorius AG, and Cell Genix GmbH, which are expected to witness significant growth in the coming years. In December 2020, Merck collaborated with Siemens to build a modular plant at its Darmstadt site with an investment of USD 12 million (EUR 10 million).
Publish Date: Jul 01, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | www.standardbio.com |
| Novogene | View profile | 501-1000 | Beijing, Beijing, China, Asia | en.novogene.com/ |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.25% in 2025.
Horizon Databook has segmented the Germany single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
Germany accounted for a substantial revenue share of Europe's single-cell analysis market. The close cooperation between research institutes, pharmaceutical & biotechnology companies, technology parks, and the government is a significant factor contributing to the market growth in Germany.
For instance, in March 2024, the Berlin Institute of Health (BIH) is focusing on research of single cells for personalized medicine. These types of research indicate the rising potential of single cell analysis in the development of personalized medicines.
Germany is home to major global biotechnology companies, such as Merck KGaA, Eppendorf AG, Sartorius AG, and Cell Genix GmbH, which are expected to witness significant growth in the coming years. In December 2020, Merck collaborated with Siemens to build a modular plant at its Darmstadt site with an investment of USD 12 million (EUR 10 million).
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Single Cell Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
